Study Shows Hydroxychloroquine’s Harmful Effects on Heart Rhythm

The malaria drug hydroxychloroquine, which has been promoted as a potential treatment for Covid-19, is known to have potentially serious effects on heart rhythms. Now, a team of researchers has used an optical mapping system to observe exactly how the drug creates serious disturbances in the electrical signals that govern heartbeat.

Read more

Study finds overwhelming support for smoke-free policies among Los Angeles tenants, landlords

Half of apartment dwellers in Los Angeles report having been exposed to unwanted secondhand smoke in their homes in the last year, and 9 in 10 of them say they favor policies banning smoking from their buildings, a new study by researchers at the Fielding School of Public Health’s UCLA Center for Health Policy Research reveals.

Read more

Theoretical breakthrough shows quantum fluids rotate by corkscrew mechanism

Scientists performed simulations of merging rotating superfluids, revealing a peculiar corkscrew-shaped mechanism that drives the fluids into rotation without the need for viscosity.

Read more

UTEP Study Examines COVID-19 Stress, Coping Strategies, and Well-Being

Emre Umucu, Ph.D., assistant professor of rehabilitation counseling at The University of Texas at El Paso, and Beatrice Lee, an incoming rehabilitation counseling faculty member, examined the perceived stress levels and coping mechanisms related to COVID-19, and how coping affects well-being in people with self-reported chronic conditions and disabilities.

Read more

Study Shows Promise for Non-Small Cell Lung Cancer Patients Who Require New Treatment Options

A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System. Early results appear promising in this phase 1/2 clinical trial of ADXS-503 being developed by Advaxis, Inc., a new type of cancer therapy which targets “hotspot” mutations that commonly occur in specific cancer types, both by itself and in combination with immunotherapy Keytruda® (pembrolizumab), which is commonly used to treat this type of lung cancer. Dr. Haigentz and colleagues published early results of this study in conjunction with ASCO 2020, the world’s premier scientific meeting for clinical research in oncology.

Read more

People more likely to accept nudges if they know how they work and how effective they are

The more people know about when and why behavioural interventions are being used and their effectiveness, the more likely they are to accept their use to change their behaviour, according to recent research from Queen Mary University of London and the University of Oxford.

Read more